Blue Scorpion Venom (VENOM) and ResearchCoin (RSC) compared side by side. Their daily returns move barely together (correlation 0.20 across 21 shared trading days). RSC has been the more volatile of the two, at 97% annualised against VENOM's 40%.
VENOMRSC
0.20over 21 shared trading days
Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.
| Metric | VENOM | RSC |
|---|---|---|
| Max drawdown (400d) | -22.4% | -38.3% |
| Risk-adjusted return (90d) | -0.50 | -0.27 |
Relative strength over 90 days: VENOM outperformed RSC by 3.6% — measured on the VENOM/RSC ratio, so it holds regardless of market direction.